Skip to main navigation
Nektar Therapeutics
  • About Nektar
    • Our Story
    • Leadership
    • Partnering for Innovation
    • Contact Us
  • Our Pipeline
    • Pipeline
    • Clinical Trials
  • Our Science
    • Scientific Approach
    • Scientific Publications
  • Investors
    • Investor Overview
    • Financials & Filings
    • Press Releases
    • SEC Filings
    • Investor Events
    • Corporate Governance
    • Stock Information
    • Contact IR
    • Historic Stock Lookup
    • Email Alerts
    • Analyst Coverage
  • Our Culture
    • Careers at Nektar
  • For Patients
  • linkedin
Nektar Therapeutics
  • About Nektar
    • Our Story
    • Leadership
    • Partnering for Innovation
    • Contact Us
  • Our Pipeline
    • Pipeline
    • Clinical Trials
  • Our Science
    • Scientific Approach
    • Scientific Publications
  • Investors
    • Investor Overview
    • Financials & Filings
    • Press Releases
    • SEC Filings
    • Investor Events
    • Corporate Governance
    • Stock Information
    • Contact IR
    • Historic Stock Lookup
    • Email Alerts
    • Analyst Coverage
  • Our Culture
    • Careers at Nektar
  • For Patients
  • linkedin
investor relations hero

SEC filing details

Document Details

Form
144
Filing Date
Feb 18, 2026
Document Date
Feb 18, 2026
Form Description
Filed by "insiders" prior intended sale of restricted stock.
Filing Group
Other
Company
Nektar Therapeutics
Issuer
NEKTAR THERAPEUTICS

Filing Formats

View HTML
Download PDF
Download DOC
Contact IR
Print Page
RSS
Email Alerts
Nektar Therapeutics
  • About Nektar
  • Our Pipeline
  • Our Science
  • Investors
  • Our Culture
  • For Patients
  • linkedin

©2026 Nektar Therapeutics

  • Privacy Policy
  • Terms of Use